The Science We Missed: How Menstrual Blood Is Changing Medicine

For centuries, menstrual blood was largely ignored in medicine.

Not studied.
Not prioritised.
Often dismissed entirely.

And yet — it may hold some of the most promising insights into human health, repair and disease.

Today, that’s beginning to change.

Researchers are now exploring menstrual blood as a powerful biological resource — and what they’re finding is reshaping how we think about everything from endometriosis to regenerative medicine.

What Makes Menstrual Blood So Unique?

Menstrual blood isn’t just “shed lining.”

It contains a rich mix of:

• Immune cells

• Endometrial tissue

• Growth factors

• Stem cells

These stem cells — often referred to as menstrual-derived stem cells (MenSCs) — have the ability to:

• Regenerate tissue

• Reduce inflammation

• Support healing processes

And importantly, they can be collected non-invasively — making them an accessible and underutilised source for research.

A New Frontier in Endometriosis Research

One of the most exciting areas of development is in endometriosis.

Historically, studying endometriosis has been challenging — largely because of limited access to live human tissue models.

Now, researchers are using menstrual tissue to:

• Build more accurate models of endometrial behaviour

• Better understand how lesions develop

• Explore new treatment pathways beyond symptom management

The goal is not just to manage endometriosis — but to better understand, and potentially change, how the disease progresses.

Beyond Gynaecology: Regenerative Medicine

The potential of menstrual-derived stem cells extends far beyond reproductive health.

Early research suggests they may play a role in:

• Wound healing and tissue repair

• Cardiovascular recovery

• Neurological research

• Anti-inflammatory therapies

These cells appear to have strong regenerative and immunomodulatory properties — meaning they can both repair tissue and influence how the immune system responds.

Why Has This Taken So Long?

The short answer: research bias.

Historically, women+ health — particularly menstruation — has been underfunded and under-researched.

Only in recent decades has there been a meaningful shift toward:

• Studying female-specific biology

• Investing in reproductive health research

• Recognising the broader implications of these findings

What’s emerging now is not “new” biology — but newly prioritised science.

What This Means for the Future

While much of this research is still in early stages, the implications are significant.

We may see:

• More accurate models for conditions like endometriosis

• New approaches to managing inflammation

• Advances in regenerative therapies

• A deeper understanding of the menstrual cycle as a whole-body process

It’s a reminder that what was once overlooked may hold some of the most valuable answers.

A Shift in Perspective

Menstrual blood has long been framed as something to manage, hide, or minimise.

But science is starting to tell a different story.

One of potential.
Of complexity.
And of innovation.

At Elgin House, we see this as part of a broader shift — toward taking women+ health seriously, investing in research, and building care models that reflect the full picture of the body.

References

• Hudson Institute of Medical Research — Endometrial and reproductive health research

• Regenerative Medicine — Stem cell and tissue repair applications

• Stem Cell Research & Therapy — Menstrual stem cell studies

• Frontiers in Cell and Developmental Biology — Endometrial stem cell research

• Human Reproduction Update — Endometriosis and tissue modelling